Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shorter versus standard duration low molecular weight heparin after total knee replacement
ACTRN12613000240741Phase 4Completed
- Sponsor
- Southern Sydney Hematology
- Start
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of enoxaparin in deep vein thrombosis (DVT) (2 arms), sponsored by Southern Sydney Hematology. Primary endpoint: Postoperative clotting episodes. Started Dec 2011; status: completed.
02
Drugs
enoxaparin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on ACTRN12613000240741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000240741.